Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Costello

Showing results (281-290 of 368) with videos related to

Pageof 37
Sort By:
Neuro-Oncology|December 23, 2023
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expressionChristina L Appin, Chibo Hong, Abigail K Suwala, et al.
Nature Communications|November 26, 2014
Regulatory network decoded from epigenomes of surface ectoderm-derived cell typesRebecca F Lowdon, Bo Zhang, Misha Bilenky, et al.
European Journal of Endocrinology|August 15, 2023
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndromeHelena J Teede, Chau Thien Tay, Joop J E Laven, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2023
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeHelena J Teede, Chau Thien Tay, Joop J E Laven, et al.
The Pharmacogenomics Journal|January 11, 2012
Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3L Chen, C Hong, E C Chen, et al.
Human Molecular Genetics|October 5, 2012
Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasivenessSónia Moniz, Olga Martinho, Filipe Pinto, et al.
Neuro-Oncology|March 14, 2022
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implicationsEsraa Mohamed, Anupam Kumar, Yalan Zhang, et al.
Lancet (London, England)|May 12, 2026
Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus processHelena J Teede, Mahnaz Bahri Khomami, Rachel Morman, et al.
The Journal of Clinical Investigation|March 21, 2017
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomasGary Kohanbash, Diego A Carrera, Shruti Shrivastav, et al.
BMC Medicine|June 26, 2008
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cellsJoachim Silber, Daniel A Lim, Claudia Petritsch, et al.
Pageof 37

Showing results (281-290 of 368) with videos related to

Sort By:
Pageof 37
Neuro-Oncology|December 23, 2023
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expressionChristina L Appin, Chibo Hong, Abigail K Suwala, et al.
Nature Communications|November 26, 2014
Regulatory network decoded from epigenomes of surface ectoderm-derived cell typesRebecca F Lowdon, Bo Zhang, Misha Bilenky, et al.
European Journal of Endocrinology|August 15, 2023
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndromeHelena J Teede, Chau Thien Tay, Joop J E Laven, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2023
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeHelena J Teede, Chau Thien Tay, Joop J E Laven, et al.
The Pharmacogenomics Journal|January 11, 2012
Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3L Chen, C Hong, E C Chen, et al.
Human Molecular Genetics|October 5, 2012
Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasivenessSónia Moniz, Olga Martinho, Filipe Pinto, et al.
Neuro-Oncology|March 14, 2022
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implicationsEsraa Mohamed, Anupam Kumar, Yalan Zhang, et al.
Lancet (London, England)|May 12, 2026
Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus processHelena J Teede, Mahnaz Bahri Khomami, Rachel Morman, et al.
The Journal of Clinical Investigation|March 21, 2017
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomasGary Kohanbash, Diego A Carrera, Shruti Shrivastav, et al.
BMC Medicine|June 26, 2008
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cellsJoachim Silber, Daniel A Lim, Claudia Petritsch, et al.
Pageof 37